Stay updated on Safety of Tarlatamab in Adults With SCLC Clinical Trial
Sign up to get notified when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.

Latest updates to the Safety of Tarlatamab in Adults With SCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check34 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4 and changed the date from 2025-03-25 to 2025-02-14.SummaryDifference1.0%
- Check77 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check84 days agoChange DetectedThe date for an event has been updated from December 13, 2024, to February 14, 2025.SummaryDifference0.9%
- Check92 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
Stay in the know with updates to Safety of Tarlatamab in Adults With SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.